Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Aquamarine Financial (Cayman) Ltd reported a 6.04% stake in Oramed Pharmaceuticals Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Aquamarine Financial (Cayman) Ltd reported a 6.04% stake in Oramed Pharmaceuticals Inc., 2,512,175 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.04%
- Shares
- 2,512,175
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 6.04% | 2,512,175 |
Source
Related
- Oramed Pharmaceuticals Inc.
- Aquamarine Financial (Cayman) Ltd
- Oramed Pharmaceuticals Inc. shareholders
- Schedule 13G · Aquamarine Financial (Cayman) Ltd · May 15, 2026
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026